Nigeria Moves To Strengthen Capacity For Converting Research Into Health Solutions

Nigeria is taking new steps to improve its ability to transform scientific research into real-world healthcare solutions, as the National Institute for Pharmaceutical Research and Development (NIPRD) prepares to host the 2026 SPARK Africa Translational Research Bootcamp and Scientific Conference.

In a statement by the Federal Ministry of Health and Social Welfare, on Tuesday,

the programme is being organised in partnership with Stanford University’s SPARK Global initiative. Translational research, the focus of the event, is considered a crucial link between laboratory discoveries and practical applications in clinical care, public health, and industry.

According to experts, many scientific breakthroughs in Africa fail to progress beyond early research stages due to limited technical capacity, weak industry linkages, and inadequate support systems. The Abuja event is expected to deepen Nigeria’s understanding of how to bridge this gap.

Director-General of NIPRD, Dr. Obi Adigwe, noted that translational research requires more than laboratory work, as it brings together science, healthcare delivery, policy considerations, and socio-economic realities to ensure that research outputs lead to measurable outcomes.

“Moving discoveries from the bench to real use requires knowledge, mentorship, and systems that support innovation,” he said.

The SPARK programme established at Stanford University more than two decades ago has supported over 1,000 research projects, contributed to the launch of several startups, and facilitated products that have advanced into clinical trials. Its global expansion to more than 40 academic institutions aims to equip countries with the skills and structures necessary for turning research into practical solutions.

Nigeria’s hosting of the 2026 Africa edition follows previous meetings held in Zimbabwe (2023) and Mozambique (2024). Analysts say the decision places Nigeria within ongoing continental efforts to reduce reliance on imported medical products and to strengthen homegrown innovation.

NIPRD, the local partner for the event, has played a central role in Nigeria’s recent research initiatives. The institute developed the country’s first National Plan for Vaccine Research and Development, which contributed to securing an €18 million European Union grant for strengthening local vaccine manufacturing. It also coordinated the National Scientific Advisory Committee during the COVID-19 pandemic, producing guidance documents for regulating locally developed phytomedicines.

Stakeholders say the Abuja conference could provide Nigerian researchers with exposure to international mentors and a deeper understanding of the processes required to advance innovations from early-stage research to development, testing, and deployment.

The initiative, they add, aligns with ongoing government reforms aimed at improving research capacity, expanding local pharmaceutical production, and positioning Nigeria as a competitive player in science and technology on the African continent.

The 2026 programme is expected to bring researchers, policymakers, and industry experts together to explore practical approaches for improving the continent’s innovation pipeline and ensuring that scientific work better responds to public health needs.